0001209191-17-058477.txt : 20171031
0001209191-17-058477.hdr.sgml : 20171031
20171031181205
ACCESSION NUMBER: 0001209191-17-058477
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171031
FILED AS OF DATE: 20171031
DATE AS OF CHANGE: 20171031
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 171166861
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-10-31
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2017-10-31
4
S
0
900
142.40
D
89810
D
Common Stock
2017-10-31
4
S
0
2800
143.49
D
87010
D
Common Stock
2017-10-31
4
S
0
17362
144.47
D
69648
D
Common Stock
2017-10-31
4
S
0
12438
145.26
D
57210
D
Common Stock
2017-10-31
4
S
0
3200
146.53
D
54010
D
Common Stock
2017-10-31
4
S
0
2200
147.70
D
51810
D
Common Stock
2017-10-31
4
S
0
1000
148.35
D
50810
D
Common Stock
2017-10-31
4
S
0
100
149.34
D
50710
D
Common Stock
882
I
401(k)
Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $142.40 (range $141.83 to $142.70).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $143.49 (range $142.87 to $143.85).
Open market sales reported on this line occurred at a weighted average price of $144.47 (range $143.90 to $144.89).
Open market sales reported on this line occurred at a weighted average price of $145.26 (range $144.93 to $145.87).
Open market sales reported on this line occurred at a weighted average price of $146.53 (range $146.16 to $147.14).
Open market sales reported on this line occurred at a weighted average price of $147.70 (range $147.18 to $148.15).
Open market sales reported on this line occurred at a weighted average price of $148.35 (range $148.19 to $148.70).
/s/ Omar White, Attorney-in-Fact
2017-10-31